Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-20-064378
Date:2020-12-15
Issuer: AMNEAL PHARMACEUTICALS, INC. (AMRX)
Original Submission Date:

Reporting Person:

GEORGE JEFFREY P.
C/O AMNEAL PHARMACEUTICALS, INC.
400 CROSSING BOULEVARD BRIDGEWATER, NJ 08807

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
CLASS A COMMON STOCK 2020-12-15 M 7,522 a $0.00 31,332 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2020-12-15 deemed execution date M 7,522 (d) class a common stock 7,522 $0.00 0 direct
Footnotes
IDfootnote
f1 each restricted stock units represents a contingent right to receive on share of the issuer's class a common stock.
f2 on december 14, 2019, the reporting person was granted 7,522 restricted stock units vesting on december 15, 2020.
WhaleWisdom Logo

Elevate your investments